{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T06:39:46Z","timestamp":1782974386433,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T00:00:00Z","timestamp":1531267200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T00:00:00Z","timestamp":1531267200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000098","name":"NIH Clinical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000098","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12890-018-0681-x","type":"journal-article","created":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T12:22:36Z","timestamp":1531311756000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Pulmonary tumor thrombotic microangiopathy and pulmonary veno-occlusive disease in a woman with cervical cancer treated with cediranib and durvalumab"],"prefix":"10.1186","volume":"18","author":[{"given":"Dante A.","family":"Suffredini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Min","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cody J.","family":"Peer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew","family":"Pratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Kleiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M.","family":"Elinoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,11]]},"reference":[{"issue":"3","key":"681_CR1","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/1097-0142(19900801)66:3<587::AID-CNCR2820660330>3.0.CO;2-J","volume":"66","author":"A von Herbay","year":"1990","unstructured":"von Herbay A, Illes A, Waldherr R, Otto HF. Pulmonary tumor thrombotic microangiopathy with pulmonary hypertension. Cancer. 1990;66(3):587\u201392.","journal-title":"Cancer"},{"issue":"12","key":"681_CR2","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.2169\/internalmedicine.52.9472","volume":"52","author":"H Uruga","year":"2013","unstructured":"Uruga H, Fujii T, Kurosaki A, Hanada S, Takaya H, Miyamoto A, Morokawa N, Homma S, Kishi K. Pulmonary tumor thrombotic microangiopathy: a clinical analysis of 30 autopsy cases. Intern Med. 2013;52(12):1317\u201323.","journal-title":"Intern Med"},{"issue":"5","key":"681_CR3","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00428-013-1403-7","volume":"462","author":"H Abe","year":"2013","unstructured":"Abe H, Hino R, Fukayama M. Platelet-derived growth factor-a and vascular endothelial growth factor-C contribute to the development of pulmonary tumor thrombotic microangiopathy in gastric cancer. Virchows Arch. 2013;462(5):523\u201331.","journal-title":"Virchows Arch"},{"issue":"4","key":"681_CR4","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1177\/2045893217728072","volume":"7","author":"R Godbole","year":"2017","unstructured":"Godbole R, Saggar R, Zider A, Betancourt J, Wallace WD, Suh RD, Kamangar N. Insights on pulmonary tumor thrombotic microangiopathy: a seven-patient case series. Pulm Circ. 2017;7(4):813\u201320.","journal-title":"Pulm Circ"},{"issue":"1","key":"681_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1056\/NEJMcps1011918","volume":"366","author":"MC Gavin","year":"2012","unstructured":"Gavin MC, Morse D, Partridge AH, Levy BD, Loscalzo J. Clinical problem-solving. Breathless. N Engl J Med. 2012;366(1):75\u201381.","journal-title":"N Engl J Med"},{"issue":"3","key":"681_CR6","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1148\/rg.273065194","volume":"27","author":"AA Frazier","year":"2007","unstructured":"Frazier AA, Franks TJ, Mohammed TL, Ozbudak IH, Galvin JR. From the archives of the AFIP: pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis. Radiographics. 2007;27(3):867\u201382.","journal-title":"Radiographics"},{"issue":"6","key":"681_CR7","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1053\/j.sult.2012.04.002","volume":"33","author":"CS Restrepo","year":"2012","unstructured":"Restrepo CS, Betancourt SL, Martinez-Jimenez S, Gutierrez FR. Tumors of the pulmonary artery and veins. Semin Ultrasound CT MR. 2012;33(6):580\u201390.","journal-title":"Semin Ultrasound CT MR"},{"issue":"7","key":"681_CR8","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1097\/00003072-198207000-00005","volume":"7","author":"RJ Boudreau","year":"1982","unstructured":"Boudreau RJ, Lisbona R, Sheldon H. Ventilation-perfusion mismatch in tumor embolism. Clin Nucl Med. 1982;7(7):320\u20132.","journal-title":"Clin Nucl Med"},{"issue":"2","key":"681_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.4103\/2045-8932.97594","volume":"2","author":"WR Auger","year":"2012","unstructured":"Auger WR, Kerr KM, Kim NH, Fedullo PF. Evaluation of patients with chronic thromboembolic pulmonary hypertension for pulmonary endarterectomy. Pulm Circ. 2012;2(2):155\u201362.","journal-title":"Pulm Circ"},{"issue":"2","key":"681_CR10","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1056\/NEJM198907133210202","volume":"321","author":"RG Masson","year":"1989","unstructured":"Masson RG, Krikorian J, Lukl P, Evans GL, McGrath J. Pulmonary microvascular cytology in the diagnosis of lymphangitic carcinomatosis. N Engl J Med. 1989;321(2):71\u20136.","journal-title":"N Engl J Med"},{"issue":"12","key":"681_CR11","first-page":"1519","volume":"120","author":"VS Rambihar","year":"1979","unstructured":"Rambihar VS, Fallen EL, Cairns JA. Pulmonary veno-occlusive disease: antemortem diagnosis from roentgenographic and hemodynamic findings. Can Med Assoc J. 1979;120(12):1519\u201322.","journal-title":"Can Med Assoc J"},{"issue":"2","key":"681_CR12","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ajpath.2014.10.021","volume":"185","author":"B Ranchoux","year":"2015","unstructured":"Ranchoux B, Gunther S, Quarck R, Chaumais MC, Dorfmuller P, Antigny F, Dumas SJ, Raymond N, Lau E, Savale L, et al. Chemotherapy-induced pulmonary hypertension: role of alkylating agents. Am J Pathol. 2015;185(2):356\u201371.","journal-title":"Am J Pathol"},{"issue":"4","key":"681_CR13","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1378\/chest.104.4.1282","volume":"104","author":"MR Kramer","year":"1993","unstructured":"Kramer MR, Estenne M, Berkman N, Antoine M, de Francquen P, Lipski A, Jacobovitz D, Lafair J. Radiation-induced pulmonary veno-occlusive disease. Chest. 1993;104(4):1282\u20134.","journal-title":"Chest"},{"issue":"4","key":"681_CR14","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1183\/13993003.00052-2015","volume":"46","author":"N Kumar","year":"2015","unstructured":"Kumar N, Price LC, Montero MA, Dimopoulos K, Wells AU, Wort SJ. Pulmonary tumour thrombotic microangiopathy: unclassifiable pulmonary hypertension? Eur Respir J. 2015;46(4):1214\u20137.","journal-title":"Eur Respir J"},{"issue":"5","key":"681_CR15","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/MCP.0000000000000297","volume":"22","author":"LC Price","year":"2016","unstructured":"Price LC, Wells AU, Wort SJ. Pulmonary tumour thrombotic microangiopathy. Curr Opin Pulm Med. 2016;22(5):421\u20138.","journal-title":"Curr Opin Pulm Med"},{"issue":"19","key":"681_CR16","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1200\/JCO.2016.72.1340","volume":"35","author":"JM Lee","year":"2017","unstructured":"Lee JM, Cimino-Mathews A, Peer CJ, Zimmer A, Lipkowitz S, Annunziata CM, Cao L, Harrell MI, Swisher EM, Houston N, et al. Safety and Clinical Activity of the Programmed Death-Ligand 1 Inhibitor Durvalumab in Combination With Poly (ADP-Ribose) Polymerase Inhibitor Olaparib or Vascular Endothelial Growth Factor Receptor 1\u20133 Inhibitor Cediranib in Women's Cancers: A Dose-Escalation, Phase I Study. J Clin Oncol. 2017;35(19):2193\u2013202.","journal-title":"J Clin Oncol"},{"issue":"3","key":"681_CR17","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/path.953","volume":"195","author":"RM Tuder","year":"2001","unstructured":"Tuder RM, Chacon M, Alger L, Wang J, Taraseviciene-Stewart L, Kasahara Y, Cool CD, Bishop AE, Geraci M, Semenza GL, et al. Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis. J Pathol. 2001;195(3):367\u201374.","journal-title":"J Pathol"},{"issue":"4","key":"681_CR18","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1165\/rcmb.2014-0045TR","volume":"51","author":"NF Voelkel","year":"2014","unstructured":"Voelkel NF, Gomez-Arroyo J. The role of vascular endothelial growth factor in pulmonary arterial hypertension. The angiogenesis paradox. Am J Respir Cell Mol Biol. 2014;51(4):474\u201384.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"681_CR19","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1200\/JCO.2009.24.8252","volume":"28","author":"S Kopetz","year":"2010","unstructured":"Kopetz S, Hoff PM, Morris JS, Wolff RA, Eng C, Glover KY, Adinin R, Overman MJ, Valero V, Wen S, et al. Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with therapeutic resistance. J Clin Oncol. 2010;28(3):453\u20139.","journal-title":"J Clin Oncol"},{"issue":"8","key":"681_CR20","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1172\/JCI70212","volume":"123","author":"J Welti","year":"2013","unstructured":"Welti J, Loges S, Dimmeler S, Carmeliet P. Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer. J Clin Invest. 2013;123(8):3190\u2013200.","journal-title":"J Clin Invest"},{"issue":"18","key":"681_CR21","doi-asserted-by":"publisher","first-page":"5489","DOI":"10.1158\/1078-0432.CCR-16-3216","volume":"23","author":"T Cascone","year":"2017","unstructured":"Cascone T, Xu L, Lin HY, Liu W, Tran HT, Liu Y, Howells K, Haddad V, Hanrahan E, Nilsson MB, et al. The HGF\/c-MET pathway is a driver and biomarker of VEGFR-inhibitor resistance and vascular remodeling in non-small cell lung Cancer. Clin Cancer Res. 2017;23(18):5489\u2013501.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"681_CR22","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1161\/CIRCRESAHA.114.302221","volume":"114","author":"PM George","year":"2014","unstructured":"George PM, Oliver E, Dorfmuller P, Dubois OD, Reed DM, Kirkby NS, Mohamed NA, Perros F, Antigny F, Fadel E, et al. Evidence for the involvement of type I interferon in pulmonary arterial hypertension. Circ Res. 2014;114(4):677\u201388.","journal-title":"Circ Res"},{"key":"681_CR23","doi-asserted-by":"publisher","first-page":"14079","DOI":"10.1038\/ncomms14079","volume":"8","author":"LA Hurst","year":"2017","unstructured":"Hurst LA, Dunmore BJ, Long L, Crosby A, Al-Lamki R, Deighton J, Southwood M, Yang X, Nikolic MZ, Herrera B, et al. TNFalpha drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling. Nat Commun. 2017;8:14079.","journal-title":"Nat Commun"},{"issue":"1","key":"681_CR24","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1161\/CIRCRESAHA.113.301141","volume":"115","author":"M Rabinovitch","year":"2014","unstructured":"Rabinovitch M, Guignabert C, Humbert M, Nicolls MR. Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. Circ Res. 2014;115(1):165\u201375.","journal-title":"Circ Res"},{"issue":"7","key":"681_CR25","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1182\/blood-2009-12-255125","volume":"116","author":"A Kondo","year":"2010","unstructured":"Kondo A, Yamashita T, Tamura H, Zhao W, Tsuji T, Shimizu M, Shinya E, Takahashi H, Tamada K, Chen L, et al. Interferon-gamma and tumor necrosis factor-alpha induce an immunoinhibitory molecule, B7-H1, via nuclear factor-kappaB activation in blasts in myelodysplastic syndromes. Blood. 2010;116(7):1124\u201331.","journal-title":"Blood"},{"issue":"1","key":"681_CR26","doi-asserted-by":"publisher","first-page":"e1005356","DOI":"10.1371\/journal.ppat.1005356","volume":"12","author":"CR Cunningham","year":"2016","unstructured":"Cunningham CR, Champhekar A, Tullius MV, Dillon BJ, Zhen A, de la Fuente JR, Herskovitz J, Elsaesser H, Snell LM, Wilson EB, et al. Type I and type II interferon coordinately regulate suppressive dendritic cell fate and function during viral persistence. PLoS Pathog. 2016;12(1):e1005356.","journal-title":"PLoS Pathog"},{"issue":"2","key":"681_CR27","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMra1703481","volume":"378","author":"MA Postow","year":"2018","unstructured":"Postow MA, Sidlow R, Hellmann MD. Immune-related adverse events associated with immune checkpoint blockade. N Engl J Med. 2018;378(2):158\u201368.","journal-title":"N Engl J Med"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-018-0681-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12890-018-0681-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-018-0681-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T11:21:48Z","timestamp":1589455308000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-018-0681-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,11]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["681"],"URL":"https:\/\/doi.org\/10.1186\/s12890-018-0681-x","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,11]]},"assertion":[{"value":"20 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the National Institutes of Health.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s next of kin to report details of this patient\u2019s clinical course and to publish associated clinical images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"112"}}